OGN (Organon) Retained Earnings: $1,253 Mil (As of Mar. 2026)


OGN Organon & Co OGN
71 GF Score
Price $13.47
GF Value $14.54
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Organon Retained Earnings?

Organon OGN -0.30% 71 Retained Earnings is $1,253 Mil as of Mar. 2026. GuruFocus rates OGN with a GF Score™ of 71/100 and a GF Value™ of $14.54 (Fairly Valued). The stock has 10 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Organon's retained earnings for the quarter that ended in Mar. 2026 was $1,253 Mil.

Organon's quarterly retained earnings declined from Sep. 2025 ($1,318 Mil) to Dec. 2025 ($1,109 Mil) but then increased from Dec. 2025 ($1,109 Mil) to Mar. 2026 ($1,253 Mil).

Organon's annual retained earnings increased from Dec. 2023 ($443 Mil) to Dec. 2024 ($1,010 Mil) and increased from Dec. 2024 ($1,010 Mil) to Dec. 2025 ($1,109 Mil).


Organon  (NYSE:OGN) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Organon Retained Earnings Historical Data

* Premium members only.

The historical data trend for Organon's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organon Retained Earnings Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial -998.00 -331.00 443.00 1,010.00 1,109.00

Organon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,026.00 1,163.00 1,318.00 1,109.00 1,253.00
OGN
71GF Score
Organon & Co OGN
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organon Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $1,253 Mil mean?
Organon (OGN) has a Retained Earnings of $1,253 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Organon and its competitors.
Is Organon's Retained Earnings too high?
Organon's current Retained Earnings is $1,253 Mil. Overall, Organon has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Organon's Retained Earnings compare to AMRN and SCLX?
Organon's Retained Earnings of $1,253 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Organon and its competitors. Organon's current Retained Earnings is $1,253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organon stock overvalued right now?
Based on GuruFocus' analysis, Organon (OGN) is currently considered Fairly Valued. The stock's GF Value™ is $14.54, compared to a current price of $13.47 — trading 7.4% below its estimated fair value. The current Retained Earnings is $1,253 Mil. Organon's overall GF Score™ is 71/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Organon (OGN), the current Retained Earnings is $1,253 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organon (OGN) Overvalued in 2026?

Based on GuruFocus' analysis, Organon stock appears to be undervalued. The current stock price of $13.47 is trading 7.4% below its estimated GF Value™ of $14.54. GuruFocus considers Organon to be Fairly Valued.

Key valuation signals for OGN:

  • Retained Earnings: $1,253 Mil
  • GF Value™: $14.54 vs. price of $13.47 (7.4% below fair value)
  • GF Score™: 71/100 with 10 warning signs

No single metric tells the full story. See the OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organon Business Description

Address 30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
71GF Score

Get the complete analysis for OGN

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.47
Price
$14.54
GF Value